【レポートの概要（一部）】
Table of Contents
PART 01: Executive summary
• Alternate therapies hinder the growth possibilities of approved therapies
PART 02: Scope of the report
• Market overview
• Assumptions
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Highlights
PART 05: Market landscape
• Market overview
• Five forces analysis
PART 06: Market segmentation by product type
• Global mAbs market
• Global human insulin market
• Global clotting factors market
• Global EPO market
• Global human growth hormone market
PART 07: Market segmentation by therapy area
• Metabolic and endocrine disorders
• Hematopoiesis
• Fertility
• Cancer
• Autoimmune diseases
• Infectious diseases
• Protein vaccine
PART 08: Market segmentation by protein function
• Enzymatic and regulatory activity
• Special targeting activity
• Vaccines
• Protein diagnostics
PART 09: Geographical segmentation
• Protein therapeutics market in Americas
• Protein therapeutics market in EMEA
• Protein therapeutics market in APAC
PART 10: Market drivers
• Increased demand for mAbs
• Development of novel therapies using innovative technologies
• Availability of favorable reimbursement policies
PART 11: Impact of drivers
PART 12: Market challenges
• Complexities in manufacturing, storage conditions, distribution policies, and high cost
• Complicated regulatory framework
• Alternate therapies loom large
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Emergence of next-generation biologics
• Advent of biosimilars expected to improve the treatment rates
• Strategic alliances further boost the R&D efforts
PART 15: Vendor landscape
• Competitive scenario
• Market share analysis 2016
• Other prominent vendors
PART 16: Key vendor analysis
• F. Hoffmann-La Roche
• Novo Nordisk
• Amgen
• AbbVie
• Johnson & Johnson
• Merck
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Overview of protein therapeutics market 2016-2021
Exhibit 03: Key strategies in global protein therapeutics market
Exhibit 04: Global protein therapeutics market snapshot: Developed and emerging markets 2015
Exhibit 05: Global protein therapeutics market 2016-2021 ($ billions)
Exhibit 06: Patent expirations of major biologics 2000-2030
Exhibit 07: Impact of factors affecting the market 2016 and 2021
Exhibit 08: Five forces analysis
Exhibit 09: Segmentation of global protein therapeutics market by product type
Exhibit 10: Market share of global protein therapeutics market by product type
Exhibit 11: Overview of global mAbs market
Exhibit 12: Annual treatment cost per patient for various drugs 2015
Exhibit 13: Global mAbs market: Present and future scenario
Exhibit 14: Global mAbs market 2016-2021 ($ billions)
Exhibit 15: Opportunity analysis of global mAbs market
Exhibit 16: Year-over-year (YoY) sales comparison of mAbs 2013-2015 ($ billions)
Exhibit 17: Market overview of human insulin
Exhibit 18: Global human insulin market 2016-2021 ($ billions)
Exhibit 19: Factors affecting global human insulin market
Exhibit 20: Opportunity analysis of global human insulin market
Exhibit 21: Revenues from the sales of top five products in insulin market 2013-2015 ($ billions)
Exhibit 22: Market overview of clotting factors
Exhibit 23: Global clotting factors market 2016-2021 ($ billions)
Exhibit 24: Opportunity analysis of global clotting factors market
Exhibit 25: Market overview of EPO
Exhibit 26: Global EPO market 2016-2021 ($ billions)
Exhibit 27: Globally approved EPO biosimilars
Exhibit 28: Opportunity analysis of global EPO market
Exhibit 29: Market overview of human growth hormone
Exhibit 30: Global human growth hormone market 2016-2021 ($ billions)
Exhibit 31: Opportunity analysis of global human growth hormone market
Exhibit 32: Segmentation of global protein therapeutics market by therapy area
Exhibit 33: Segmentation of global protein therapeutics market by protein function
Exhibit 34: Global protein therapeutics market: Segmentation by geography (2016-2021)
Exhibit 35: Global protein therapeutics market segmentation by region: Market growth lifecycle analysis 2016
Exhibit 36: Overview of protein therapeutics market in Americas
Exhibit 37: Protein therapeutics market in Americas 2016-2021 ($ billions)
Exhibit 38: Protein therapeutics market in Americas: Opportunity analysis
Exhibit 39: Overview of protein therapeutics market in EMEA
Exhibit 40: Protein therapeutics market in EMEA 2016-2021 ($ billions)
Exhibit 41: Protein therapeutics market in EMEA: Opportunity analysis
Exhibit 42: Overview of protein therapeutics market in APAC
Exhibit 43: Protein therapeutics market in APAC 2016-2021 ($ billions)
Exhibit 44: Protein therapeutics market in APAC: Opportunity analysis
Exhibit 45: mAb approvals by the US FDA and EMA 2010-2015
Exhibit 46: Advances in ADCs technology
Exhibit 47: Few of other technologies used in protein therapeutics
Exhibit 48: Impact of drivers
Exhibit 49: Approval process of biologicals versus biosimilars via Public Health Service Act (PHSA) in US
Exhibit 50: Few of CAM therapies used for autoimmune and inflammatory diseases
Exhibit 51: Impact of drivers and challenges
Exhibit 52: Overview of next-generation antibodies
Exhibit 53: Oral insulin pipeline portfolio
Exhibit 54: Few of the biosimilars under development
Exhibit 55: Key deals in global protein therapeutics market
Exhibit 56: Market presence of vendors in various therapy areas 2015
Exhibit 57: Competitive assessment of vendors
Exhibit 58: Geographical presence of key vendors
Exhibit 59: F. Hoffmann-La Roche: Profile
Exhibit 60: F. Hoffmann-La Roche: Strength assessment
Exhibit 61: F. Hoffmann-La Roche: Strategy assessment
Exhibit 62: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 63: Novo Nordisk: Profile
Exhibit 64: Novo Nordisk: Strength assessment
Exhibit 65: Novo Nordisk: Strategy assessment
Exhibit 66: Novo Nordisk: Opportunity assessment
Exhibit 67: Amgen: Profile
Exhibit 68: Amgen: Strength assessment
Exhibit 69: Amgen strategy assessment
Exhibit 70: Amgen: Opportunity assessment
Exhibit 71: AbbVie: Profile
Exhibit 72: AbbVie: Strength assessment
Exhibit 73: AbbVie: Strategy assessment
Exhibit 74: AbbVie: Opportunity assessment
Exhibit 75: Johnson & Johnson: Profile
Exhibit 76: Johnson & Johnson: Strength assessment
Exhibit 77: Johnson & Johnson: Strategy assessment
Exhibit 78: Johnson & Johnson: Opportunity assessment
Exhibit 79: Merck: Profile
Exhibit 80: Merck: Strength assessment
Exhibit 81: Merck: Strategy assessment
Exhibit 82: Merck: Opportunity assessment
【レポート販売概要】
■ タイトル：蛋白質治療の世界市場2017-2021：mAbs、ヒトインスリン、凝固因子、EPO、ヒト成長ホルモン■ 英文：Global Protein Therapeutics Market 2017-2021
■ 発行日：2016年12月29日
■ 調査会社：Technavio
■ 商品コード：IRTNTR11316
■ 調査対象地域：グローバル
- 農業用生物製剤の世界市場：バイオ農薬、バイオ肥料、バイオスティミュラントThe global agricultural biologicals market is projected to reach USD 10.05 Billion by 2020, growing at a CAGR of 14.5% from 2015 to 2020. The demand for biologicals is also fueled because major agriculture firms intend to continue and preserve their market share or produce incremental income streams; governmental regulatory bodies are actively participating in environmental conservation issues; gr …
- プロトン交換膜燃料電池（PEMFC）の世界市場About PEMFC PEMFC are devices that generate electricity through an electrochemical process involving oxidation of electrolytes placed between the anode and the cathode. Fuel cells are generally categorized based on the type of electrolyte used. PEMFC use an acidic water-based polymer membrane with platinum-based electrodes. It operates at low temperatures and caters effectively to dynamic power re …
- グローバルにおける政府部門向けGIS（地理情報システム）市場（2014-2018）About Geographic Information Systems A GIS is a set of tools used to interpret geographical or geospatial data or information. This system digitizes the received geospatial data and processes (stores, interprets, analyzes, and manipulates) them to provide the required output. TechNavio's analysts forecast the Global GIS market in the Government sector will grow at a CAGR of 10.00 percent over the …
- アデノシンの世界市場2015Adenosine (CAS 58-61-7) Market Research Report 2015 aims at providing comprehensive data on Adenosine market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Adenosine description, covers its application areas, manufacturing methods, patterns. It captures Adenosine market trends, pays close attention to Adenosine manufacturers and names suppliers. Besid …
- マシニングセンタ（MC）の世界市場2016-2020About Machining Centers A machining center may be defined as a machine tool that has the ability to perform multiple operations or processes by utilizing the different axes of the setup. The basic characteristic of a machining center is its ability to change tools automatically. The motion of the cutting tool can be programmed according to the nature of the work and tool movement can be controlled …
- 不動産管理ソフトウェアの世界市場2016-2020About Property Management Software A property management software enables end-users to perform core real estate operations in a more efficient manner. The software, which has various applications in the real estate industry, primarily helps enterprises and brokers to manage the sales or purchases of properties. Using this software, property or real estate firms can perform various tasks such as pr …
- ディーゼルポータブル発電機の世界市場2015-2019About generators Generators provide temporary AC or DC power by using supplied fuel such as gasoline, diesel, and gas. They can be used as a source of backup or emergency power for residential, commercial, and industrial applications. A typical generator is powered via a fuel engine. Portable generators are the best solutions to provide AC power for standby non-hardwired applications. Low-end mode …
- 顔認識システムの世界市場2015-2019About Facial Recognition Facial recognition is a technology used for the identification of individuals. Facial recognition system measures the overall facial feature of a person such as nose, jaw edges, mouth, and the distance between eyes. Facial recognition is used for access control in restricted or high-security areas such as private and public buildings. Facial recognition is largely used in …
- ゼオライトの世界市場：天然ゼオライト、合成ゼオライトAbout Zeolite Zeolites are alumina silicate and microporous minerals that are available naturally and also can be produced synthetically. They have a three-dimensional crystalline structure of tetrahedral arrangements of alumina or siliceous anions that are sturdily bonded at corners. The zeolite structure contains (–Si–O–Al–) linkages. These linkages form even sized pores on the surface and form …
- 世界のリモコン市場：スマートテレビ/セットトップボックス/ゲームコンソール用リモコンAbout Remotes Remotes/remote controls are devices that are used to wirelessly operate electronic gadgets such as smart TVs, set top boxes, and gaming consoles from a short line-of-sight distance. Remote controls are small wireless handheld devices that enable users to adjust various settings such as tracking number and volume. Basically, there are two popular types of remote controls that are most …
- 北米の手術室用装置市場見通し（～2021）North America Operating Room Equipment Market Outlook to 2021 Summary GlobalData’s new report, "North America Operating Room Equipment Market Outlook to 2021", provides key market data on the North America Operating Room Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Operating Room Tables, O …
- 腫瘍向けコンパニオン診断：グローバル市場分析と予測MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts Summary A companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows the safe application of a therapy. In-vitro Companion Diagnostic tests measure the expression or presence of a specific biomarker that is linked to a disease condition or therapy. This report pro …
- ポリウレタン分散の世界市場予測（～2024年）“Increasing demand from automobile, textile and leather industries to drive the overall growth of polyurethane dispersion market”The polyurethane dispersion (PUDs) market size is expected to grow from USD 2.4 billion in 2019 to USD 3.4 billion by 2024, at a CAGR of 7.1% during the forecast period. The PUDs market is driven by various factors, such as high demand from textile & leather industry, an …
- ボーディング・ブリッジ（搭乗橋）の世界市場2017-2021About Aerobridge Aerobridges were mainly introduced for passenger comfort. Passengers with disabilities face difficulty in climbing up and down the stairs laid on the apron to board a flight. These passengers usually require the help of crew to board and disembark from an aircraft. This slows down the boarding process and increases the layover time for flights causing delays. Use of aerobridges as …
- 多発神経根筋障害治療のグローバル臨床試験動向（2014年下半期）Polyradiculoneuropathy Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Polyradiculoneuropathy Global Clinical Trials Review, H2, 2014" provides data on the Polyradiculoneuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Polyradiculoneuropathy. It includes an overview of the trial numbers and …
